Feedback / Questions
brilaroxazine (RP5063) - Reviva
https://www.psychiatrictimes.com/view/open-label-phase-3-study-of-brilaroxazine-for-schizophrenia-shows-efficacy-tolerability
Jun 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next